×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NMRA – neumora therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NMRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/6
07:00 am
nmra
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
Medium
Report
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
4/1
02:04 pm
nmra
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Medium
Report
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
3/31
09:21 am
nmra
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Guggenheim. They now have a $14.00 price target on the stock.
Low
Report
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Guggenheim. They now have a $14.00 price target on the stock.
3/31
08:02 am
nmra
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
Low
Report
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
3/30
09:11 pm
nmra
Neumora Therapeutics Inc (NMRA) Q4 2025 Earnings Call Highlights: Strong Financial Position ... [Yahoo! Finance]
Low
Report
Neumora Therapeutics Inc (NMRA) Q4 2025 Earnings Call Highlights: Strong Financial Position ... [Yahoo! Finance]
3/30
06:53 am
nmra
Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
High
Report
Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3/25
04:32 pm
nmra
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
3/19
07:27 pm
nmra
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Date
Time
Symbol
Company Name
Action
%Chg
3/30/2026
06:53 am
nmra
neumora therapeutics, inc.
MISS
Report
-17.9%
neumora therapeutics, inc.
11/6/2025
07:00 am
nmra
neumora therapeutics, inc.
MISS
Report
-0.8%
neumora therapeutics, inc.
8/6/2025
04:05 pm
nmra
neumora therapeutics, inc.
BEAT
Report
3.8%
neumora therapeutics, inc.
5/12/2025
04:01 pm
nmra
neumora therapeutics, inc.
MISS
Report
-1.9%
neumora therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/17
04:06 pm
nmra
Form DEFA14A Neumora Therapeutics,
Low
Report
Form DEFA14A Neumora Therapeutics,
4/17
04:05 pm
nmra
Form DEF 14A Neumora Therapeutics, For: May 27
Low
Report
Form DEF 14A Neumora Therapeutics, For: May 27
4/1
04:10 pm
nmra
Form SCHEDULE 13D/A Neumora Therapeutics, Filed by: ARCH Venture Fund XII, L.P.
Medium
Report
Form SCHEDULE 13D/A Neumora Therapeutics, Filed by: ARCH Venture Fund XII, L.P.
3/30
07:08 am
nmra
Form 10-K Neumora Therapeutics, For: Dec 31
High
Report
Form 10-K Neumora Therapeutics, For: Dec 31
3/30
06:59 am
nmra
Form 8-K Neumora Therapeutics, For: Mar 30
High
Report
Form 8-K Neumora Therapeutics, For: Mar 30
2/19
05:07 pm
nmra
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Aurora Daljit Singh
Low
Report
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Aurora Daljit Singh
2/19
05:06 pm
nmra
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Pinto Joshua
Low
Report
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Pinto Joshua
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: